Corcept Therapeutics
CORT
CORT
96 hedge funds and large institutions have $199M invested in Corcept Therapeutics in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 35 increasing their positions, 23 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 97 → 96 (-1)
7% less capital invested
Capital invested by funds: $215M → $199M (-$16M)
Holders
96
Holding in Top 10
2
Calls
$167K
Puts
$8K
Top Buyers
| 1 | +$1.91M | |
| 2 | +$815K | |
| 3 | +$691K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$607K |
| 5 |
First Eagle Investment Management
New York
|
+$448K |
Top Sellers
| 1 | -$1.67M | |
| 2 | -$1.26M | |
| 3 | -$871K | |
| 4 |
D.E. Shaw & Co
New York
|
-$772K |
| 5 |
Two Sigma Investments
New York
|
-$452K |